Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib

Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib

Item
http://www.wikidata.org/entity/Q41956993
Potential approaches to the treatment of Ewing's sarcomaRNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma.ABT-869 inhibits the proliferation of Ewing Sarcoma cells and suppresses platelet-derived growth factor receptor beta and c-KIT signaling pathways.Comparative evaluation of strategies for quantifying signaling pathway proteins in Ewing sarcoma.Molecular profiling of childhood cancer: Biomarkers and novel therapiesPediatric developmental therapies: interesting new drugs now in early-stage clinical trials.Dual targeting of the insulin-like growth factor and collateral pathways in cancer: combating drug resistance.The Scandinavian Sarcoma Group: 30 years' experience.Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors.
P2860

Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib

Item
http://www.wikidata.org/entity/Q41956993
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Proliferation of Ewing sarcoma ...... itors gefitinib and vandetanib
@en
type
label
Proliferation of Ewing sarcoma ...... itors gefitinib and vandetanib
@en
prefLabel
Proliferation of Ewing sarcoma ...... itors gefitinib and vandetanib
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Proliferation of Ewing sarcoma ...... itors gefitinib and vandetanib
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P932